254 Incidence of leiomyosarcoma after the FDA warning against the power morcellator – have we made an impact? | International Journal of Gynecologic Cancer

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Current issue

Archive

Authors

About
Subscribe
Log in More

Log in via Institution
Log in via OpenAthens
Log in via your Society

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

Poster

IGCS20_1264

254 Incidence of leiomyosarcoma after the FDA warning against the power morcellator – have we made an impact?

Free

Online download statistics by month:

Online download statistics by month: November 2020 to March 2023

	Abstract	Full	Pdf
Nov 2020	28	0	9
Dec 2020	19	0	9
Jan 2021	8	0	2
Feb 2021	4	0	2
Mar 2021	20	0	2
Apr 2021	13	0	3
May 2021	2	0	1
Jun 2021	1	0	2
Jul 2021	1	0	5
Aug 2021	0	0	2
Sep 2021	2	0	2
Oct 2021	2	0	12
Nov 2021	15	0	16
Dec 2021	4	0	2
Jan 2022	7	0	0
Feb 2022	8	0	0
Mar 2022	2	0	1
Apr 2022	17	0	2
May 2022	12	0	8
Jun 2022	5	0	3
Jul 2022	19	0	0
Aug 2022	15	0	3
Sep 2022	14	0	6
Oct 2022	4	0	2
Nov 2022	18	0	1
Dec 2022	10	0	3
Jan 2023	10	0	2
Feb 2023	10	0	0
Mar 2023	7	0	1
Total	277	0	101